Platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary revascularization

Keyphrases

• Percutaneous Coronary Intervention 100%
• Glycoprotein IIb/IIIa Inhibitors 100%
• Percutaneous Coronary Revascularization 100%
• Platelet Glycoproteins 100%
• Coronary Dissection 66%
• Intracoronary Thrombosis 66%
• Anticoagulation 33%
• Aspirin 33%
• Platelets 33%
• Pathogenic Mechanism 33%
• Stent 33%
• Coronary Intervention 33%
• Unfractionated Heparin 33%
• Ischemic Outcomes 33%
• Antiplatelet Agents 33%
• Arterial Thrombosis 33%
• Acute Complications 33%
• Intracoronary Thrombus 33%
• Important Determinant 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Thrombosis 100%
• Fibrinogen Receptor Antagonist 100%
• Acetylsalicylic Acid 50%
• Heparin 50%
• Thrombus 50%
• Artery Thrombosis 50%
• Antithrombocytic Agent 50%
• Pathogenesis 50%